Long-term immune reconstitution after anti-CD52–treated or anti-CD34–treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency

This publication has 23 references indexed in Scilit:

• Quantitative Assessment of Mixed Chimerism in Allogeneic Stem Cell Transplant Patients
  Journal of Pediatric Hematology/Oncology, 2007
• Lymphocyte subsets in term and significantly preterm UK infants in the first year of life analysed by single platform flow cytometry
  Clinical and Experimental Immunology, 2005
• Severe combined immunodeficiency. A model disease for molecular immunology and therapy
  Immunological Reviews, 2005
• Polysaccharide antibody responses are impaired post bone marrow transplantation for severe combined immunodeficiency, but not other primary immunodeficiencies
  Bone Marrow Transplantation, 2003
• Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99
  The Lancet, 2003
• Immune reconstitution after autologous selectedperipheral blood progenitor cell transplantation:comparison of two CD34+ cell‐selection systems
  Transfusion, 2001
• CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987–98 in a single center
  Cytotherapy, 2001
• Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion
  Experimental Hematology, 2001
• Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined Immunodeficiency
  New England Journal of Medicine, 1999
• In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID)
  Bone Marrow Transplantation, 1997